CA2366665C - Polymer coated stent - Google Patents
Polymer coated stent Download PDFInfo
- Publication number
- CA2366665C CA2366665C CA002366665A CA2366665A CA2366665C CA 2366665 C CA2366665 C CA 2366665C CA 002366665 A CA002366665 A CA 002366665A CA 2366665 A CA2366665 A CA 2366665A CA 2366665 C CA2366665 C CA 2366665C
- Authority
- CA
- Canada
- Prior art keywords
- stent
- tubular
- graft
- polymeric coating
- partially
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/89—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/072—Encapsulated stents, e.g. wire or whole stent embedded in lining
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/075—Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
Abstract
A tubular intraluminal prosthesis includes a PTFE or ePTFE tubular structure such as a graft, and a tubular diametrically deformable stent circumferentially surrounding the tubular structure. The diametrically deformable stent includes a polymeric coating which allows for attachment to the tubular graft structure and enhances the biocompatibility and integrity of the composite prosthesis.
Description
POLYMER COATED STENT
FIELD OF INVENTION:
The present invention relates generally to a tubular implantable prosthesis formed of porous polytetrafluoroethylene. More particularly, the present invention relates to a stent/graft composite device including a polymeric coated stent in conjunction with an ePTFE graft.
BACKGROUND OF RELATED TECHNOLOGY
An endoluminal prosthesis is a medical device commonly known to be used in the treatment of diseased blood vessels. An endoluminal prosthesis is typically used to repair, replace, or otherwise correct a damaged blood vessel. An artery or vein may be diseased in a variety of different ways. The prosthesis may therefore be used to prevent or treat a wide variety of defects such as stenosis of the vessel, thrombosis, occlusion, or an aneurysm.
One type of endoluminal prosthesis used in the repair of diseases in various body vessels is a stent. A stent is a generally longitudinal tubular device which is useful to open and support various lumens in the body. For example, stents may be used in the vascular system, urogenital tract and bile duct, as well as in a variety of other applications in the body.
Endovascular stents have become widely used for the treatment of stenosis, strictures, and aneurysms in various blood vessels. These devices are implanted within the vessel to open and/or reinforce collapsing or partially occluded sections of the vessel.
Stents are generally open ended and are radially expandable between a generally unexpanded insertion diameter and an expanded implantation diameter which is greater than the unexpanded insertion diameter. Stents are often flexible in configuration, which allows them to be inserted through and conform to tortuous pathways in the blood vessel. The stent is generally inserted in a radially compressed state and expanded either through a self-expanding mechanism, or through the use of balloon catheters.
A graft is another type of endoluminal prosthesis which is used to repair and replace various body vessels. Whereas a stent provides structural support to hold a damaged vessel open, a graft provides an artificial lumen through which blood may flow. Grafts are tubular devices which may be formed of a variety of material, including textile and non-textile materials. One type of non-textile material particularly suitable for use as an implantable prosthesis is polytetrafluoroethylene (PTFE). PTFE exhibits superior biocompatibility and low thrombogenicity, which makes it particularly useful as vascular graft material in the repair or replacement of blood vessels. In vascular applications, the grafts are manufactured from expanded PTFE (ePTFE) tubes. These tubes have a microporous structure which allows natural tissue ingrowth and cell endothelialization once implanted in the vascular system. This contributes to long term healing and patency of the graft.
FIELD OF INVENTION:
The present invention relates generally to a tubular implantable prosthesis formed of porous polytetrafluoroethylene. More particularly, the present invention relates to a stent/graft composite device including a polymeric coated stent in conjunction with an ePTFE graft.
BACKGROUND OF RELATED TECHNOLOGY
An endoluminal prosthesis is a medical device commonly known to be used in the treatment of diseased blood vessels. An endoluminal prosthesis is typically used to repair, replace, or otherwise correct a damaged blood vessel. An artery or vein may be diseased in a variety of different ways. The prosthesis may therefore be used to prevent or treat a wide variety of defects such as stenosis of the vessel, thrombosis, occlusion, or an aneurysm.
One type of endoluminal prosthesis used in the repair of diseases in various body vessels is a stent. A stent is a generally longitudinal tubular device which is useful to open and support various lumens in the body. For example, stents may be used in the vascular system, urogenital tract and bile duct, as well as in a variety of other applications in the body.
Endovascular stents have become widely used for the treatment of stenosis, strictures, and aneurysms in various blood vessels. These devices are implanted within the vessel to open and/or reinforce collapsing or partially occluded sections of the vessel.
Stents are generally open ended and are radially expandable between a generally unexpanded insertion diameter and an expanded implantation diameter which is greater than the unexpanded insertion diameter. Stents are often flexible in configuration, which allows them to be inserted through and conform to tortuous pathways in the blood vessel. The stent is generally inserted in a radially compressed state and expanded either through a self-expanding mechanism, or through the use of balloon catheters.
A graft is another type of endoluminal prosthesis which is used to repair and replace various body vessels. Whereas a stent provides structural support to hold a damaged vessel open, a graft provides an artificial lumen through which blood may flow. Grafts are tubular devices which may be formed of a variety of material, including textile and non-textile materials. One type of non-textile material particularly suitable for use as an implantable prosthesis is polytetrafluoroethylene (PTFE). PTFE exhibits superior biocompatibility and low thrombogenicity, which makes it particularly useful as vascular graft material in the repair or replacement of blood vessels. In vascular applications, the grafts are manufactured from expanded PTFE (ePTFE) tubes. These tubes have a microporous structure which allows natural tissue ingrowth and cell endothelialization once implanted in the vascular system. This contributes to long term healing and patency of the graft.
2 It is also known to combine a stent and a graft to form a composite medical device. Such devices are often referred to as stent/grafts. Such a composite medical device provides additional support for blood flow through weakened sections of a blood vessel. In endovascular applications the use of a stent/graft combination is becoming increasingly important because the combination not only effectively allows the passage of blood therethrough, but also ensures the implant will remain open and stable. However, the graft can reduce the overall longitudinal flexibility of the composite device. Longitudinal flexibility is of particular importance to such stent/graft endoluminal prosthesis as the device must be intraluminally delivered through tortuous pathways of a blood vessel to the implantation site where the stent is expanded.
Several types of stent/graft inventions are known in the art. For example, U.S. Patent No.
5,151,105 issued to Kwan-Gett discloses a collapsible textile vessel sleeve that is collapsible to a very small diameter in order that it may be placed in position within the abdominal or thoracic aorta by a catheter via the lumen of the femoral artery. Such a procedure obviates the need for a major surgical intervention, and reduces the risks associated with such a procedure.
Other stent/graft composite devices using a fabric are shown in U.S. Patent No. 5,628,788 to Pinchuck.
U.S. Patent No. 5,575,818 issued to Pinchuk discloses polyurethane coatings which may be applied to a stent to form a stentJgraft. The coatings disclosed may be bonded to the stent through the use of many different methods. For example, an inner lining or coating can be first spun on a mandrel, after which a stent covered with an adhesive substance is pulled down on the lining and then the adhesive is cured, melted and solidified or dried. Another alternative is to place the stent
Several types of stent/graft inventions are known in the art. For example, U.S. Patent No.
5,151,105 issued to Kwan-Gett discloses a collapsible textile vessel sleeve that is collapsible to a very small diameter in order that it may be placed in position within the abdominal or thoracic aorta by a catheter via the lumen of the femoral artery. Such a procedure obviates the need for a major surgical intervention, and reduces the risks associated with such a procedure.
Other stent/graft composite devices using a fabric are shown in U.S. Patent No. 5,628,788 to Pinchuck.
U.S. Patent No. 5,575,818 issued to Pinchuk discloses polyurethane coatings which may be applied to a stent to form a stentJgraft. The coatings disclosed may be bonded to the stent through the use of many different methods. For example, an inner lining or coating can be first spun on a mandrel, after which a stent covered with an adhesive substance is pulled down on the lining and then the adhesive is cured, melted and solidified or dried. Another alternative is to place the stent
3 on a mandrel, apply (e.g., spray, dip, pad, etc.) a thin coating of polyurethane lacquer over the stent, and then spin the coating over the lacquer so that it is bonded to the stent once the lacquer dries.
One difficulty encountered in stent/graft structures which employ PTFE or ePTFE as the graft portion, is obtaining a proper bond between the stent, which is usually metallic or other material dissimilar to the graft portion. For example, U.S. Patent Nos.
5,700,285, 5,735,892 and 5,810,870 to Myers et al. disclose the use of two ePTFE tubular sheets which are bonded together through the space between a stent sandwiched therebetween. These patents also disclose the use of fluorinated ethylene propylene (FEP) as an adhesive for bonding the stent to a tubular sheet or sheets.
It is well recognized, however, that few materials bond well to PTFE or ePTFE
due to its chemical makeup. The surface of PTFE materials is difficult to wet and the relatively small pore sizes of ePTFE are difficult to penetrate effectively to obtain good mechanical bonds.
Thus, while ePTFE has shown to possess many desirous characteristics for use in conjunction with a stent, attachment of the polymeric tubular grafts to the stent has always presented its challenges. Due to the physical and chemical inertness of an ePTFE vascular graft, thus, it is difficult to adheringly attach such grafts to other structures. The present invention addresses inherent difficulty in bonding the stent.
One difficulty encountered in stent/graft structures which employ PTFE or ePTFE as the graft portion, is obtaining a proper bond between the stent, which is usually metallic or other material dissimilar to the graft portion. For example, U.S. Patent Nos.
5,700,285, 5,735,892 and 5,810,870 to Myers et al. disclose the use of two ePTFE tubular sheets which are bonded together through the space between a stent sandwiched therebetween. These patents also disclose the use of fluorinated ethylene propylene (FEP) as an adhesive for bonding the stent to a tubular sheet or sheets.
It is well recognized, however, that few materials bond well to PTFE or ePTFE
due to its chemical makeup. The surface of PTFE materials is difficult to wet and the relatively small pore sizes of ePTFE are difficult to penetrate effectively to obtain good mechanical bonds.
Thus, while ePTFE has shown to possess many desirous characteristics for use in conjunction with a stent, attachment of the polymeric tubular grafts to the stent has always presented its challenges. Due to the physical and chemical inertness of an ePTFE vascular graft, thus, it is difficult to adheringly attach such grafts to other structures. The present invention addresses inherent difficulty in bonding the stent.
4 SUMMARY OF THE INVENTION
It is therefore an advantage provided by the present invention to provide a composite stent/grafft prosthesis exhibiting both the benefits of a composite endoluminal stentlgraft prosthesis while maintaining the flexibility of an uncovered stent.
It is a further advantage provided by the present invention to provide a biocompatible surface to an uncovered stent through the application of a polymeric material coating which is capable of adhereing to PTFE or ePTFE.
In the efficient attainment of these and other objects, the present invention provides a tubular intraluminal prosthesis including at least one PTFE tubular structure with opposed interior and exterior surfaces. A tubular diametrically deformable stent is at least partially coated with a polymeric coating, and the at least partially coated stent is affixed to said tubular structure at the portions of the stent. A second PTFE tubular structure on the remaining uncovered side of the stent is also contemplated.
A method of forming the intraluminal prosthesis is also provided, which includes the providing a tubular stent, coating at least a portion of said stent with a polymeric coating applied from a liquid or particulate state, providing a tubular PTFE graft structure, and affixing said coated stent to said tubular PTFE graft structure.
It is therefore an advantage provided by the present invention to provide a composite stent/grafft prosthesis exhibiting both the benefits of a composite endoluminal stentlgraft prosthesis while maintaining the flexibility of an uncovered stent.
It is a further advantage provided by the present invention to provide a biocompatible surface to an uncovered stent through the application of a polymeric material coating which is capable of adhereing to PTFE or ePTFE.
In the efficient attainment of these and other objects, the present invention provides a tubular intraluminal prosthesis including at least one PTFE tubular structure with opposed interior and exterior surfaces. A tubular diametrically deformable stent is at least partially coated with a polymeric coating, and the at least partially coated stent is affixed to said tubular structure at the portions of the stent. A second PTFE tubular structure on the remaining uncovered side of the stent is also contemplated.
A method of forming the intraluminal prosthesis is also provided, which includes the providing a tubular stent, coating at least a portion of said stent with a polymeric coating applied from a liquid or particulate state, providing a tubular PTFE graft structure, and affixing said coated stent to said tubular PTFE graft structure.
5 BRIEF DESCRIPTION OF THE DRAWINGS:
Figure 1 is a perspective showing of a collapsed standard wave-like stent which may be used in the present intraluminal prosthesis.
Figure 2 is a perspective showing of a collapsed standard wave-like stent with a polymeric coating.
Figure 3 is a perspective showing of the coated stent of Figure 2 expanded over a mandrel.
Figure 4 is a perspective showing of an ePTFE tube formed from a wrapped sheet.
Figure 5 is a perspective showing of the coated stent of Figure 2 positioned over an ePTFE
tube of Figure 4.
Figure 6 is a perspective showing of a further embodiment of the present invention employing a stent with a partial polymeric coating over a PTFE tube.
Figure 7 is a perspective showing a different type of a stent which may be used in the present invention.
Figure 1 is a perspective showing of a collapsed standard wave-like stent which may be used in the present intraluminal prosthesis.
Figure 2 is a perspective showing of a collapsed standard wave-like stent with a polymeric coating.
Figure 3 is a perspective showing of the coated stent of Figure 2 expanded over a mandrel.
Figure 4 is a perspective showing of an ePTFE tube formed from a wrapped sheet.
Figure 5 is a perspective showing of the coated stent of Figure 2 positioned over an ePTFE
tube of Figure 4.
Figure 6 is a perspective showing of a further embodiment of the present invention employing a stent with a partial polymeric coating over a PTFE tube.
Figure 7 is a perspective showing a different type of a stent which may be used in the present invention.
6
7 PCT/US00/05976 DETAILED DESCRIPTION OF THE INVENTION:
The following is a detailed description of the preferred embodiments of the present invention.
The description is meant to describe preferred embodiments, and is not meant to limit the invention in any way.
Various stent types and stent constructions may be employed in the invention.
Among the various stents useful include, without limitation, self-expanding stents and balloon expandable extents. The stents may be capable of radially contracting, as well, and in this sense can best be described as radially distensible or deformable. Self-expanding stents include those that have a spring-like action which causes the stent to radially expand, or stents which expand due to the memory properties of the stent material for a particular configuration at a certain temperature.
Nitinol is one material which has the ability to perform well while both in spring-like mode, as well as in a memory mode based on temperature. Other materials are of course contemplated, such as stainless steel, platinum, gold, titanium and other biocompatible metals, as well as polymeric stents.
The configuration of the stent may also be chosen from a host of geometries.
For example, wire stents can be fastened into a continuous helical pattern, with or without a wave-like or zig-zag in the wire, to form a radially deformable stent. Individual rings or circular members can be linked together such as by struts, sutures, welding or interlacing or locking of the rings to form a tubular stent. Tubular stents useful in the present invention also include those formed by etching or cutting a pattern from a tube. Such stents are often referred to as slotted stents.
Furthermore, stents may be formed by etching a pattern into a material or mold and depositing stent material in the pattern, such as by chemical vapor deposition or the like.
The present invention provides a stent/graft composite endoluminal prostheses 22 shown in Figure 5 including a stent 2 of the type shown in Figure 1 secured to a tubular graft 16 of the type shown in Figure 4. An improved method of forming such composite structure in accordance with the present invention includes providing a an adhesive bond between stent 2 and graft 16 by use of a polymeric coating 14 on stent 2 as shown in Figure 2.
Referring specifically to Figures 1 and 2 of the drawings, one type of stent which may be included in the composite endoluminal prosthesis of the present invention is shown. Stent 2 is formed from an elongate wire 4 which is helically wound with a plurality of longitudinally spaced turns into an open tubular configuration. Stent 2 is an expandable tubular member which may be either of the balloon-expandable or self-expandable type. As previously discussed, one type of self-expanding stent may be formed of a shaped memory material such as nitinol. The elongate helically wound wire 4 forming stent 2 defines successive upper wave-like peaks 10 and lower wave-like peaks 12. Wire 4 is wound into a specific configuration where upper peaks 10 are placed adjacent to lower peaks 12 of the next adjacent winding.
In order to effectively form the composite endoluminal prosthesis of the present invention, stent 2 is coated with polymeric coating 14. Polymeric coating 14 is a biocompatible material, desirably PTFE. Polymeric coatings useful in the present invention include those biocompatible
The following is a detailed description of the preferred embodiments of the present invention.
The description is meant to describe preferred embodiments, and is not meant to limit the invention in any way.
Various stent types and stent constructions may be employed in the invention.
Among the various stents useful include, without limitation, self-expanding stents and balloon expandable extents. The stents may be capable of radially contracting, as well, and in this sense can best be described as radially distensible or deformable. Self-expanding stents include those that have a spring-like action which causes the stent to radially expand, or stents which expand due to the memory properties of the stent material for a particular configuration at a certain temperature.
Nitinol is one material which has the ability to perform well while both in spring-like mode, as well as in a memory mode based on temperature. Other materials are of course contemplated, such as stainless steel, platinum, gold, titanium and other biocompatible metals, as well as polymeric stents.
The configuration of the stent may also be chosen from a host of geometries.
For example, wire stents can be fastened into a continuous helical pattern, with or without a wave-like or zig-zag in the wire, to form a radially deformable stent. Individual rings or circular members can be linked together such as by struts, sutures, welding or interlacing or locking of the rings to form a tubular stent. Tubular stents useful in the present invention also include those formed by etching or cutting a pattern from a tube. Such stents are often referred to as slotted stents.
Furthermore, stents may be formed by etching a pattern into a material or mold and depositing stent material in the pattern, such as by chemical vapor deposition or the like.
The present invention provides a stent/graft composite endoluminal prostheses 22 shown in Figure 5 including a stent 2 of the type shown in Figure 1 secured to a tubular graft 16 of the type shown in Figure 4. An improved method of forming such composite structure in accordance with the present invention includes providing a an adhesive bond between stent 2 and graft 16 by use of a polymeric coating 14 on stent 2 as shown in Figure 2.
Referring specifically to Figures 1 and 2 of the drawings, one type of stent which may be included in the composite endoluminal prosthesis of the present invention is shown. Stent 2 is formed from an elongate wire 4 which is helically wound with a plurality of longitudinally spaced turns into an open tubular configuration. Stent 2 is an expandable tubular member which may be either of the balloon-expandable or self-expandable type. As previously discussed, one type of self-expanding stent may be formed of a shaped memory material such as nitinol. The elongate helically wound wire 4 forming stent 2 defines successive upper wave-like peaks 10 and lower wave-like peaks 12. Wire 4 is wound into a specific configuration where upper peaks 10 are placed adjacent to lower peaks 12 of the next adjacent winding.
In order to effectively form the composite endoluminal prosthesis of the present invention, stent 2 is coated with polymeric coating 14. Polymeric coating 14 is a biocompatible material, desirably PTFE. Polymeric coatings useful in the present invention include those biocompatible
8 materials which are capable of adhering to PTFE grafts and desirably ePTFE
grafts. Among those coatings contemplated are polytetrafluoroethylene (PTFE), expanded PTFE
(ePTFE), polyurethane, fluorinated ethylene propylene (FEP), silicone, polyurethane-acrylate, silicone-acrylate, urethane-silicone, and the like. Combinations of these polymers may also be useful.
Portions of the stent may also be coated with different polymers.
One particularly desirable form of polymer coating is one formed by polymeric particles or powder. PTFE powder coatings have been found to be especially useful in the present invention since these coatings bond well under heat and pressure to ePTFE tubular grafts. Other coatings are contemplated, however, and can include those which can flow into the porous structure of the graft or which are capable of bonding to PTFE or ePTFE.
The polymeric coating may be applied to stent 2 using a number of different techniques.
Two preferred examples of application of coating 14 include spraying the stent with a spray of PTFE
particles or dip coating the stent in a mixture containing PTFE particles.
Powder coating generally refers to a variety of methods employing powdered plastics and resins which are used commercially to apply coatings to various articles: These methods include fluidized bed, electrostatic spray, electrostatic fluidized bed, plasma spray, and hot flocking, as well as combinations and variants of these methods.
grafts. Among those coatings contemplated are polytetrafluoroethylene (PTFE), expanded PTFE
(ePTFE), polyurethane, fluorinated ethylene propylene (FEP), silicone, polyurethane-acrylate, silicone-acrylate, urethane-silicone, and the like. Combinations of these polymers may also be useful.
Portions of the stent may also be coated with different polymers.
One particularly desirable form of polymer coating is one formed by polymeric particles or powder. PTFE powder coatings have been found to be especially useful in the present invention since these coatings bond well under heat and pressure to ePTFE tubular grafts. Other coatings are contemplated, however, and can include those which can flow into the porous structure of the graft or which are capable of bonding to PTFE or ePTFE.
The polymeric coating may be applied to stent 2 using a number of different techniques.
Two preferred examples of application of coating 14 include spraying the stent with a spray of PTFE
particles or dip coating the stent in a mixture containing PTFE particles.
Powder coating generally refers to a variety of methods employing powdered plastics and resins which are used commercially to apply coatings to various articles: These methods include fluidized bed, electrostatic spray, electrostatic fluidized bed, plasma spray, and hot flocking, as well as combinations and variants of these methods.
9 In the electrostatic spray process, a coating powder is withdrawn from a reservoir in an air stream and electrostatically charged in the high voltage corona field of a spray gun. The charged particles are attracted to the grounded metal object to be coated and adhere to it by electrostatic attraction. The coated substrate is then placed in an oven and the coating is fused to form a substantially continuous film. The discrete PTFE particles form a connected path around the stent.
The relatively high viscosity of the PTFE melt serves to effectuate a superior coating. If the powder is sprayed on a preheated article, the powder melts and fuses directly on the hot surface; further heating to fuse or cure the coating may be required, depending upon the type of coating powder.
Plasma coating is a method comprising establishing a hot temperature plasma in an inert gas such as nitrogen, and the coating powder is introduced at the periphery of the plasma. The particles melt and are propelled at high velocity to the substrate, where they form a film. In hot flocking techniques, powders are usually dispersed in air and sprayed or blown onto the preheated substrate, where they melt and form a coating. In a variant of this process, small parts are preheated and dropped into a bed of powder kept in a mobile state by vibration. In this method, the parts are completely coated with an unfused layer of powder on the surface.
Another method for coating the stent is to suspend stent 2 in the air, such as, on a hook, and spray the polymeric coating onto the stent according to the electrostatic spray method mentioned above. An advantage of applying the powder coating in this manner, is that it would sufficiently coat the stent in its entirety, and thus provide improved adhesion at its mating surface to the graft.
Referring to Figure 3, a desirable method for applying coating 14 to stent 6 is shown. Stent 6 is shown in an expanded state, and may be supported on a mandrel 8. Mandrel 8 is a rod-like stainless steel member of diameter approximately equal to that of the expanded stent. Once positioned on mandrel 8, stent 6 is polymeric coated with coating 14. PTFE
polymeric coating 14 desirably forms a thin film on the wire. The thiclrness of the PTFE coating generally ranges from about 1 to about 100 microns. Coated stent 6 can then be removed from mandrel 8 tubular graft 16 to form the composite structure, or left on mandrel 8 and tubular graft 16 placed thereover.
Assembly of the stent/graft prosthesis includes the steps to positioning the graft either on the outside or the inside of the stent and using the combination of heat and pressure sufficient to adheringly assemble the components together. Tubular graft material can be used on both the interior and exterior of the tubular stent, as well. The gaft may be a continuous tube, or may be formed with discontinuous sections. Tubular wrapping in a helical pattern is also contemplated.
As shown in Figure 2, the entire stent may be coated with polymeric coating 14. It is further contemplated, however, that the stent may be partially coated with the polymeric coating at selected regions (Fig. 6) for purposes which will be described in detail hereinbelow.
Referring now to Figure 4, graft 16 is a tubular structure of conventional construction formed of ePTFE. Graft 16 may be extruded as a tube or may be formed from an extruded sheet which is subsequently formed into a tubular structure. Textile or fabric constructions formed of PTFE or ePTFE yarns, filaments or mesh may also be employed.
Figure 5 shows a perspective of a composite endoluminal prosthesis 22 comprised of stent 6 with polymeric coating 14, which circumferentially encloses ePTFE graft 16.
The PTFE
polymeric coating provides a bonding interface between the stent wire and the graft 16. The coated stent 6 is bonded to graft 16 by sintering the composite structure over a suitable mandrel such as, for example, mandrel 8 (Fig. 3).
It is further contemplated that this bonding interface may be enhanced by first coating the stent with the PTFE polymeric coating, then less than fully sintering the PTFE
coating on stent 6.
By sintering stent 6 less than fully, i.e. only partially sintering, the stent can then be placed on the ePTFE tubular graft 16 and sintered again over the mandrel. The subsequent sintering of the partially sintered coating 14 on graft 16 serves to increase bonded interface between graft 16 and stent 6.
Referring to Figure 6, a further embodiment of the present invention is shown.
A composite intraluminal prosthesis 24 is shown including an ePTFE graft 16, circumferentially enclosed by a partially coated polymeric stent 26. The composite structure may be assembled as described above.
In this embodiment of the present invention, stent 26 is partially coated with PTFE coating 14 at areas intermediate of the undulations in the stent. By partially coating stent 6, the upper and lower wave-like peaks 10, and 12 respectively, are subsequently left exteriorly exposed without PTFE coating. This embodiment provides the composite graft with increased flexibility as the unexposed peaks do not readily bond to the graft. This provides multiple points of flexure throughout the length of the composite prosthesis 22.
The particular wire stent 6 of Figures 1-6 is shown as merely one example.
Other stent configurations, as discussed above, may be employed. For example, Figure 7 shows another stent configuration which maybe used in the present invention is shown. Stent 30 may be the type more fully described in U.S. Patent No. 4,733,665. Stent 30 is an expandable and deformable tubular structure including a plurality of longitudinally extending parallel struts 31 connected to one another by transverse tabs 34.
The struts 31 and tabs 34 define slots 32 which define open spaces 35 through the tube. This stent construction not only ensures patency and flexibility with the slotted configuration, but the configuration of slots and tabs would allow for a partially covered polymeric coating with increased flexibility as shown in Figure 6. Stent 30 fully or partially coated as described above is subsequently bound to a tubular graft 16 (Fig. 4) in a manner described above to form a composite endoluminal prosthesis 22.
Various modifications and changes may be made without departing ftom the spirit and intent of the invention and all such changes are intended to be included in the following claims.
The relatively high viscosity of the PTFE melt serves to effectuate a superior coating. If the powder is sprayed on a preheated article, the powder melts and fuses directly on the hot surface; further heating to fuse or cure the coating may be required, depending upon the type of coating powder.
Plasma coating is a method comprising establishing a hot temperature plasma in an inert gas such as nitrogen, and the coating powder is introduced at the periphery of the plasma. The particles melt and are propelled at high velocity to the substrate, where they form a film. In hot flocking techniques, powders are usually dispersed in air and sprayed or blown onto the preheated substrate, where they melt and form a coating. In a variant of this process, small parts are preheated and dropped into a bed of powder kept in a mobile state by vibration. In this method, the parts are completely coated with an unfused layer of powder on the surface.
Another method for coating the stent is to suspend stent 2 in the air, such as, on a hook, and spray the polymeric coating onto the stent according to the electrostatic spray method mentioned above. An advantage of applying the powder coating in this manner, is that it would sufficiently coat the stent in its entirety, and thus provide improved adhesion at its mating surface to the graft.
Referring to Figure 3, a desirable method for applying coating 14 to stent 6 is shown. Stent 6 is shown in an expanded state, and may be supported on a mandrel 8. Mandrel 8 is a rod-like stainless steel member of diameter approximately equal to that of the expanded stent. Once positioned on mandrel 8, stent 6 is polymeric coated with coating 14. PTFE
polymeric coating 14 desirably forms a thin film on the wire. The thiclrness of the PTFE coating generally ranges from about 1 to about 100 microns. Coated stent 6 can then be removed from mandrel 8 tubular graft 16 to form the composite structure, or left on mandrel 8 and tubular graft 16 placed thereover.
Assembly of the stent/graft prosthesis includes the steps to positioning the graft either on the outside or the inside of the stent and using the combination of heat and pressure sufficient to adheringly assemble the components together. Tubular graft material can be used on both the interior and exterior of the tubular stent, as well. The gaft may be a continuous tube, or may be formed with discontinuous sections. Tubular wrapping in a helical pattern is also contemplated.
As shown in Figure 2, the entire stent may be coated with polymeric coating 14. It is further contemplated, however, that the stent may be partially coated with the polymeric coating at selected regions (Fig. 6) for purposes which will be described in detail hereinbelow.
Referring now to Figure 4, graft 16 is a tubular structure of conventional construction formed of ePTFE. Graft 16 may be extruded as a tube or may be formed from an extruded sheet which is subsequently formed into a tubular structure. Textile or fabric constructions formed of PTFE or ePTFE yarns, filaments or mesh may also be employed.
Figure 5 shows a perspective of a composite endoluminal prosthesis 22 comprised of stent 6 with polymeric coating 14, which circumferentially encloses ePTFE graft 16.
The PTFE
polymeric coating provides a bonding interface between the stent wire and the graft 16. The coated stent 6 is bonded to graft 16 by sintering the composite structure over a suitable mandrel such as, for example, mandrel 8 (Fig. 3).
It is further contemplated that this bonding interface may be enhanced by first coating the stent with the PTFE polymeric coating, then less than fully sintering the PTFE
coating on stent 6.
By sintering stent 6 less than fully, i.e. only partially sintering, the stent can then be placed on the ePTFE tubular graft 16 and sintered again over the mandrel. The subsequent sintering of the partially sintered coating 14 on graft 16 serves to increase bonded interface between graft 16 and stent 6.
Referring to Figure 6, a further embodiment of the present invention is shown.
A composite intraluminal prosthesis 24 is shown including an ePTFE graft 16, circumferentially enclosed by a partially coated polymeric stent 26. The composite structure may be assembled as described above.
In this embodiment of the present invention, stent 26 is partially coated with PTFE coating 14 at areas intermediate of the undulations in the stent. By partially coating stent 6, the upper and lower wave-like peaks 10, and 12 respectively, are subsequently left exteriorly exposed without PTFE coating. This embodiment provides the composite graft with increased flexibility as the unexposed peaks do not readily bond to the graft. This provides multiple points of flexure throughout the length of the composite prosthesis 22.
The particular wire stent 6 of Figures 1-6 is shown as merely one example.
Other stent configurations, as discussed above, may be employed. For example, Figure 7 shows another stent configuration which maybe used in the present invention is shown. Stent 30 may be the type more fully described in U.S. Patent No. 4,733,665. Stent 30 is an expandable and deformable tubular structure including a plurality of longitudinally extending parallel struts 31 connected to one another by transverse tabs 34.
The struts 31 and tabs 34 define slots 32 which define open spaces 35 through the tube. This stent construction not only ensures patency and flexibility with the slotted configuration, but the configuration of slots and tabs would allow for a partially covered polymeric coating with increased flexibility as shown in Figure 6. Stent 30 fully or partially coated as described above is subsequently bound to a tubular graft 16 (Fig. 4) in a manner described above to form a composite endoluminal prosthesis 22.
Various modifications and changes may be made without departing ftom the spirit and intent of the invention and all such changes are intended to be included in the following claims.
Claims (27)
1. A tubular intraluminal prosthesis comprising:
an ePTFE tubular graft structure having opposed interior and exterior surfaces;
a tubular diametrically deformable stent in contact with said ePTFE tubular graft structure; and said stent being partially coated with a powder polymeric coating, wherein said powder polymeric coating is at least partially sintered to said stent;
said partially coated and sintered stent being affixed to said tubular structure at said partial coating.
an ePTFE tubular graft structure having opposed interior and exterior surfaces;
a tubular diametrically deformable stent in contact with said ePTFE tubular graft structure; and said stent being partially coated with a powder polymeric coating, wherein said powder polymeric coating is at least partially sintered to said stent;
said partially coated and sintered stent being affixed to said tubular structure at said partial coating.
2. A tubular intraluminal prosthesis according to claim 1 wherein the polymeric coating is polytetrafluoroethylene.
3. A tubular intraluminal prosthesis according to claim 1 wherein the polymeric coating is partially sintered.
4. A tubular intraluminal prosthesis of claim 3 wherein said partially coated stent is sintered to said tubular structure.
5. A tubular intraluminal prosthesis of claim 3 wherein said partially coated stent is affixed to said tubular structure at selected locations.
6. A tubular intraluminal prosthesis according to claim 1 wherein the tubular diametrically deformable stent is formed from an elongate wire helically wound with a plurality of longitudinally spaced turns into an open tubular configuration, each of said turns including successive upper and lower wave-like peaks.
7. A tubular intraluminal prosthesis according to claim 6 wherein selective peaks of said upper and lower wave-like peaks of said stent are exposed exteriorly of said polymeric coating.
8. A tubular intraluminal prosthesis of claim 6 wherein the partially coated stent is affixed to said tubular structure at locations intermediate said upper and lower wave like peaks.
9. A tubular intraluminal prosthesis of claim 1 wherein said polymeric coating is selected from the group consisting of polytetrafluoroethylene, polyurethane, fluorinated ethylene propylene, silicone, silicone-acrylate, urethane-acrylate, urethane-silicone and combinations thereof.
10. A tubular intraluminal prosthesis of claim 1 wherein said deformable stent is self-expanding.
11. A tubular intraluminal prosthesis of claim 1 wherein said stent is formed of nitinol.
12. A method of forming an intraluminal prosthesis comprising the steps of:
providing a tubular stent having opposed interior and exterior surfaces;
partially coating a portion of said stent with a powder polymeric coating;
at least partially sintering said coated stent;
providing a tubular ePTFE graft structure; and affixing the interior surface of said partially sintered stent to said tubular ePTFE graft structure.
providing a tubular stent having opposed interior and exterior surfaces;
partially coating a portion of said stent with a powder polymeric coating;
at least partially sintering said coated stent;
providing a tubular ePTFE graft structure; and affixing the interior surface of said partially sintered stent to said tubular ePTFE graft structure.
13. A method according to claim 12 wherein said affixing step includes:
applying said partially coated stent to an exterior surface of said ePTFE
graft structure.
applying said partially coated stent to an exterior surface of said ePTFE
graft structure.
14. A method according to claim 12 wherein said affixing step includes:
applying sufficient heat and pressure to cause adherence of said stent to said ePTFE graft.
applying sufficient heat and pressure to cause adherence of said stent to said ePTFE graft.
15. A method according to claim 12 wherein the polymeric coating is polytetrafluoroethylene.
16. A method according to claim 12 wherein the polymeric coating is partially sintered.
17. A method according to claim 12 further includes the steps of affixing a second tubular member to the exterior surface of said stent.
18. A method according to claim 12 wherein the tubular stent is formed from an elongate wire helically wound with a plurality of longitudinally spaced turns into an open tubular configuration, each of said turns including successive upper and lower wave-like peaks.
19. A method according to claim 18 wherein selective peaks of said upper and lower wave-like peaks are exposed exteriorly of said polymeric coating.
20. A method according to claim 18 wherein the partially coated stent is affixed to said tubular structure at locations intermediate said upper and lower wave-like peaks.
21. A method according to claim 12 wherein said partially coated stent is affixed to said tubular structure at selected locations.
22. A method according to claim 12 wherein said polymeric coating is selected from the group consisting of polytetrafluorethylene, polyurethane, fluorinated ethylene propylene, silicone, silicone-acrylate, urethane-acrylate, urethane-silicone and combinations thereof.
23. A method according to claim 12 wherein the stent is self-expanding.
24. A method according to claim 12 wherein said stent is formed of nitinol.
25. A method according to claim 24 wherein said polymeric coating is partially sintered on said stent before positioning said stent with respect to said graft.
26. A method according to claim 24 further including positioning a second graft on the exterior surface of said stent and effectuating adhesion therebetween.
27. A method of forming an intraluminal prosthesis comprising the steps of:
partially coating a portion of a stent with a polymeric coating applied from a liquid or particulate state;
at least partially sintering said coated stent;
positioning said sintered stent either interior to or exterior to a graft using a support mandrel; and sintering said partially coated stent and graft to effect a bond therebetween.
partially coating a portion of a stent with a polymeric coating applied from a liquid or particulate state;
at least partially sintering said coated stent;
positioning said sintered stent either interior to or exterior to a graft using a support mandrel; and sintering said partially coated stent and graft to effect a bond therebetween.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/272,538 US6364903B2 (en) | 1999-03-19 | 1999-03-19 | Polymer coated stent |
US09/272,538 | 1999-03-19 | ||
PCT/US2000/005976 WO2000056247A1 (en) | 1999-03-19 | 2000-03-06 | Polymer coated stent |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2366665A1 CA2366665A1 (en) | 2000-09-28 |
CA2366665C true CA2366665C (en) | 2009-09-22 |
Family
ID=23040223
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002366665A Expired - Fee Related CA2366665C (en) | 1999-03-19 | 2000-03-06 | Polymer coated stent |
Country Status (6)
Country | Link |
---|---|
US (3) | US6364903B2 (en) |
EP (1) | EP1164972B1 (en) |
JP (1) | JP4672869B2 (en) |
CA (1) | CA2366665C (en) |
DE (1) | DE60019911T2 (en) |
WO (1) | WO2000056247A1 (en) |
Families Citing this family (250)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7204848B1 (en) | 1995-03-01 | 2007-04-17 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
US6579314B1 (en) * | 1995-03-10 | 2003-06-17 | C.R. Bard, Inc. | Covered stent with encapsulated ends |
US6451047B2 (en) | 1995-03-10 | 2002-09-17 | Impra, Inc. | Encapsulated intraluminal stent-graft and methods of making same |
US6264684B1 (en) | 1995-03-10 | 2001-07-24 | Impra, Inc., A Subsidiary Of C.R. Bard, Inc. | Helically supported graft |
US6433154B1 (en) | 1997-06-12 | 2002-08-13 | Bristol-Myers Squibb Company | Functional receptor/kinase chimera in yeast cells |
US6955661B1 (en) * | 1999-01-25 | 2005-10-18 | Atrium Medical Corporation | Expandable fluoropolymer device for delivery of therapeutic agents and method of making |
US7572245B2 (en) * | 2003-09-15 | 2009-08-11 | Atrium Medical Corporation | Application of a therapeutic substance to a tissue location using an expandable medical device |
US7947015B2 (en) | 1999-01-25 | 2011-05-24 | Atrium Medical Corporation | Application of a therapeutic substance to a tissue location using an expandable medical device |
US6398803B1 (en) | 1999-02-02 | 2002-06-04 | Impra, Inc., A Subsidiary Of C.R. Bard, Inc. | Partial encapsulation of stents |
US20020081732A1 (en) * | 2000-10-18 | 2002-06-27 | Bowlin Gary L. | Electroprocessing in drug delivery and cell encapsulation |
US7615373B2 (en) * | 1999-02-25 | 2009-11-10 | Virginia Commonwealth University Intellectual Property Foundation | Electroprocessed collagen and tissue engineering |
US6364903B2 (en) * | 1999-03-19 | 2002-04-02 | Meadox Medicals, Inc. | Polymer coated stent |
US6730349B2 (en) * | 1999-04-19 | 2004-05-04 | Scimed Life Systems, Inc. | Mechanical and acoustical suspension coating of medical implants |
US20070032853A1 (en) | 2002-03-27 | 2007-02-08 | Hossainy Syed F | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
US6503556B2 (en) | 2000-12-28 | 2003-01-07 | Advanced Cardiovascular Systems, Inc. | Methods of forming a coating for a prosthesis |
US7807211B2 (en) * | 1999-09-03 | 2010-10-05 | Advanced Cardiovascular Systems, Inc. | Thermal treatment of an implantable medical device |
US6953476B1 (en) * | 2000-03-27 | 2005-10-11 | Neovasc Medical Ltd. | Device and method for treating ischemic heart disease |
DE60135455D1 (en) | 2000-05-16 | 2008-10-02 | Univ Minnesota | IT OF MULTI-NOZZLE ARRANGEMENT |
AU2001288692A1 (en) * | 2000-09-01 | 2002-03-13 | Virginia Commonwealth University Intellectual Property Foundation | Electroprocessed fibrin-based matrices and tissues |
US6652574B1 (en) * | 2000-09-28 | 2003-11-25 | Vascular Concepts Holdings Limited | Product and process for manufacturing a wire stent coated with a biocompatible fluoropolymer |
US6923927B2 (en) * | 2000-10-03 | 2005-08-02 | Atrium Medical Corporation | Method for forming expandable polymers having drugs or agents included therewith |
US6616876B1 (en) * | 2000-10-03 | 2003-09-09 | Atrium Medical Corporation | Method for treating expandable polymer materials |
US7504125B1 (en) | 2001-04-27 | 2009-03-17 | Advanced Cardiovascular Systems, Inc. | System and method for coating implantable devices |
US6540776B2 (en) | 2000-12-28 | 2003-04-01 | Advanced Cardiovascular Systems, Inc. | Sheath for a prosthesis and methods of forming the same |
US7247338B2 (en) * | 2001-05-16 | 2007-07-24 | Regents Of The University Of Minnesota | Coating medical devices |
US6605154B1 (en) * | 2001-05-31 | 2003-08-12 | Advanced Cardiovascular Systems, Inc. | Stent mounting device |
US7510571B2 (en) * | 2001-06-11 | 2009-03-31 | Boston Scientific, Scimed, Inc. | Pleated composite ePTFE/textile hybrid covering |
AU2002345328A1 (en) | 2001-06-27 | 2003-03-03 | Remon Medical Technologies Ltd. | Method and device for electrochemical formation of therapeutic species in vivo |
US8741378B1 (en) | 2001-06-27 | 2014-06-03 | Advanced Cardiovascular Systems, Inc. | Methods of coating an implantable device |
US6572644B1 (en) * | 2001-06-27 | 2003-06-03 | Advanced Cardiovascular Systems, Inc. | Stent mounting device and a method of using the same to coat a stent |
US6695920B1 (en) * | 2001-06-27 | 2004-02-24 | Advanced Cardiovascular Systems, Inc. | Mandrel for supporting a stent and a method of using the mandrel to coat a stent |
US6673154B1 (en) * | 2001-06-28 | 2004-01-06 | Advanced Cardiovascular Systems, Inc. | Stent mounting device to coat a stent |
US6527863B1 (en) | 2001-06-29 | 2003-03-04 | Advanced Cardiovascular Systems, Inc. | Support device for a stent and a method of using the same to coat a stent |
US6682771B2 (en) * | 2001-07-02 | 2004-01-27 | Scimed Life Systems, Inc. | Coating dispensing system and method using a solenoid head for coating medical devices |
US8252040B2 (en) | 2001-07-20 | 2012-08-28 | Microvention, Inc. | Aneurysm treatment device and method of use |
US8715312B2 (en) | 2001-07-20 | 2014-05-06 | Microvention, Inc. | Aneurysm treatment device and method of use |
US7572288B2 (en) | 2001-07-20 | 2009-08-11 | Microvention, Inc. | Aneurysm treatment device and method of use |
JP4347044B2 (en) * | 2001-07-26 | 2009-10-21 | アバンテク バスキュラー コーポレーション | Device for delivering a therapeutic agent having a variable release profile |
US20040137066A1 (en) * | 2001-11-26 | 2004-07-15 | Swaminathan Jayaraman | Rationally designed therapeutic intravascular implant coating |
US6641611B2 (en) | 2001-11-26 | 2003-11-04 | Swaminathan Jayaraman | Therapeutic coating for an intravascular implant |
US6669980B2 (en) * | 2001-09-18 | 2003-12-30 | Scimed Life Systems, Inc. | Method for spray-coating medical devices |
US6939318B2 (en) * | 2002-05-03 | 2005-09-06 | Boston Scientific Scimed, Inc. | Method, tool, and system for deploying an implant into the body |
US7147661B2 (en) * | 2001-12-20 | 2006-12-12 | Boston Scientific Santa Rosa Corp. | Radially expandable stent |
US20100016943A1 (en) * | 2001-12-20 | 2010-01-21 | Trivascular2, Inc. | Method of delivering advanced endovascular graft |
US7070613B2 (en) * | 2002-01-04 | 2006-07-04 | Boston Scientific Scimed, Inc. | Non-compliant balloon with compliant top-layer to protect coated stents during expansion |
US20030135269A1 (en) * | 2002-01-16 | 2003-07-17 | Swanstrom Lee L. | Laparoscopic-assisted endovascular/endoluminal graft placement |
US7691461B1 (en) * | 2002-04-01 | 2010-04-06 | Advanced Cardiovascular Systems, Inc. | Hybrid stent and method of making |
US20030225439A1 (en) * | 2002-05-31 | 2003-12-04 | Cook Alonzo D. | Implantable product with improved aqueous interface characteristics and method for making and using same |
US6865810B2 (en) * | 2002-06-27 | 2005-03-15 | Scimed Life Systems, Inc. | Methods of making medical devices |
US20040024448A1 (en) | 2002-08-05 | 2004-02-05 | Chang James W. | Thermoplastic fluoropolymer-coated medical devices |
US9561123B2 (en) | 2002-08-30 | 2017-02-07 | C.R. Bard, Inc. | Highly flexible stent and method of manufacture |
US6878162B2 (en) | 2002-08-30 | 2005-04-12 | Edwards Lifesciences Ag | Helical stent having improved flexibility and expandability |
US6818063B1 (en) * | 2002-09-24 | 2004-11-16 | Advanced Cardiovascular Systems, Inc. | Stent mandrel fixture and method for minimizing coating defects |
US7776381B1 (en) * | 2002-09-26 | 2010-08-17 | Advanced Cardiovascular Systems, Inc. | Stent mandrel fixture and method for reducing coating defects |
US7335265B1 (en) | 2002-10-08 | 2008-02-26 | Advanced Cardiovascular Systems Inc. | Apparatus and method for coating stents |
US20040093056A1 (en) | 2002-10-26 | 2004-05-13 | Johnson Lianw M. | Medical appliance delivery apparatus and method of use |
US7959671B2 (en) | 2002-11-05 | 2011-06-14 | Merit Medical Systems, Inc. | Differential covering and coating methods |
US7875068B2 (en) | 2002-11-05 | 2011-01-25 | Merit Medical Systems, Inc. | Removable biliary stent |
US7637942B2 (en) | 2002-11-05 | 2009-12-29 | Merit Medical Systems, Inc. | Coated stent with geometry determinated functionality and method of making the same |
AU2003291311A1 (en) * | 2002-11-07 | 2004-06-03 | Carbon Medical Technologies, Inc. | Biocompatible medical device coatings |
US7416609B1 (en) * | 2002-11-25 | 2008-08-26 | Advanced Cardiovascular Systems, Inc. | Support assembly for a stent |
US7074276B1 (en) | 2002-12-12 | 2006-07-11 | Advanced Cardiovascular Systems, Inc. | Clamp mandrel fixture and a method of using the same to minimize coating defects |
US7628859B1 (en) * | 2002-12-27 | 2009-12-08 | Advanced Cardiovascular Systems, Inc. | Mounting assembly for a stent and a method of using the same to coat a stent |
US7763062B2 (en) * | 2003-01-21 | 2010-07-27 | Boston Scientific Scimed, Inc. | Method and system for delivering and implanting a graft |
US20040148001A1 (en) * | 2003-01-24 | 2004-07-29 | Nolting John E. | Solvent-bonded stent-graft assembly |
ES2354605T3 (en) * | 2003-02-21 | 2011-03-16 | Sorin Biomedica Cardio S.R.L. | STENTS PRODUCTION PROCEDURE AND THE CORRESPONDING STENT. |
US7354480B1 (en) | 2003-02-26 | 2008-04-08 | Advanced Cardiovascular Systems, Inc. | Stent mandrel fixture and system for reducing coating defects |
EP1462801A3 (en) * | 2003-03-24 | 2005-01-05 | Tepnel Lifecodes | Methods for determining the negative control value for multi-analyte assays |
US7637934B2 (en) | 2003-03-31 | 2009-12-29 | Merit Medical Systems, Inc. | Medical appliance optical delivery and deployment apparatus and method |
US20040199246A1 (en) * | 2003-04-02 | 2004-10-07 | Scimed Life Systems, Inc. | Expandable stent |
US20040210118A1 (en) * | 2003-04-18 | 2004-10-21 | Michel Letort | In situ detection of endoleak and endotension |
US20040213767A1 (en) * | 2003-04-23 | 2004-10-28 | Marc Hendriks | Methods for using adipose-derived cells for healing of aortic aneurysmal tissue |
US20040215318A1 (en) * | 2003-04-24 | 2004-10-28 | Brian Kwitkin | Timed delivery of therapeutics to blood vessels |
US20040254629A1 (en) * | 2003-04-25 | 2004-12-16 | Brian Fernandes | Methods and apparatus for treatment of aneurysmal tissue |
US7396540B2 (en) * | 2003-04-25 | 2008-07-08 | Medtronic Vascular, Inc. | In situ blood vessel and aneurysm treatment |
US7387645B2 (en) * | 2003-04-25 | 2008-06-17 | Medtronic Vascular, Inc. | Cellular therapy to heal vascular tissue |
US20040230298A1 (en) * | 2003-04-25 | 2004-11-18 | Medtronic Vascular, Inc. | Drug-polymer coated stent with polysulfone and styrenic block copolymer |
US20040215320A1 (en) * | 2003-04-25 | 2004-10-28 | James Machek | Integral stent graft |
US20040215335A1 (en) * | 2003-04-25 | 2004-10-28 | Brin David S. | Methods and apparatus for treatment of aneurysmal tissue |
US7323209B1 (en) * | 2003-05-15 | 2008-01-29 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for coating stents |
US8021418B2 (en) * | 2003-06-19 | 2011-09-20 | Boston Scientific Scimed, Inc. | Sandwiched radiopaque marker on covered stent |
US20050118344A1 (en) | 2003-12-01 | 2005-06-02 | Pacetti Stephen D. | Temperature controlled crimping |
US7131993B2 (en) * | 2003-06-25 | 2006-11-07 | Boston Scientific Scimed, Inc. | Varying circumferential spanned connectors in a stent |
US9861346B2 (en) | 2003-07-14 | 2018-01-09 | W. L. Gore & Associates, Inc. | Patent foramen ovale (PFO) closure device with linearly elongating petals |
US20050013870A1 (en) * | 2003-07-17 | 2005-01-20 | Toby Freyman | Decellularized extracellular matrix of conditioned body tissues and uses thereof |
US20050043786A1 (en) * | 2003-08-18 | 2005-02-24 | Medtronic Ave, Inc. | Methods and apparatus for treatment of aneurysmal tissue |
US8021331B2 (en) * | 2003-09-15 | 2011-09-20 | Atrium Medical Corporation | Method of coating a folded medical device |
JP2007505655A (en) * | 2003-09-15 | 2007-03-15 | アトリウム メディカル コーポレーション | Application of therapeutic substances to tissue sites using porous medical devices |
US20050060020A1 (en) * | 2003-09-17 | 2005-03-17 | Scimed Life Systems, Inc. | Covered stent with biologically active material |
US7371228B2 (en) * | 2003-09-19 | 2008-05-13 | Medtronic Vascular, Inc. | Delivery of therapeutics to treat aneurysms |
WO2005030091A2 (en) * | 2003-09-25 | 2005-04-07 | Scios Inc. | Stents and intra-luminal prostheses containing map kinase inhibitors |
US7198675B2 (en) | 2003-09-30 | 2007-04-03 | Advanced Cardiovascular Systems | Stent mandrel fixture and method for selectively coating surfaces of a stent |
MXPA06006470A (en) * | 2003-12-12 | 2006-08-23 | Bard Inc C R | Implantable medical devices with fluorinated polymer coatings, and methods of coating thereof. |
US20050131513A1 (en) | 2003-12-16 | 2005-06-16 | Cook Incorporated | Stent catheter with a permanently affixed conductor |
US8042485B1 (en) | 2003-12-30 | 2011-10-25 | Advanced Cardiovascular Systems, Inc. | Stent mandrel fixture and method for coating stents |
US7530994B2 (en) * | 2003-12-30 | 2009-05-12 | Scimed Life Systems, Inc. | Non-porous graft with fastening elements |
US8349388B1 (en) | 2004-03-18 | 2013-01-08 | Advanced Cardiovascular Systems, Inc. | Method of coating a stent |
US8500751B2 (en) | 2004-03-31 | 2013-08-06 | Merlin Md Pte Ltd | Medical device |
US8915952B2 (en) | 2004-03-31 | 2014-12-23 | Merlin Md Pte Ltd. | Method for treating aneurysms |
US8377110B2 (en) * | 2004-04-08 | 2013-02-19 | Endologix, Inc. | Endolumenal vascular prosthesis with neointima inhibiting polymeric sleeve |
JP2007534389A (en) * | 2004-04-29 | 2007-11-29 | キューブ・メディカル・アクティーゼルスカブ | Balloon used for angiogenesis |
US20060246109A1 (en) * | 2005-04-29 | 2006-11-02 | Hossainy Syed F | Concentration gradient profiles for control of agent release rates from polymer matrices |
US7993387B2 (en) * | 2004-05-14 | 2011-08-09 | Boston Scientific Scimed, Inc. | Stent with reduced weld profiles and a closed-end wire configuration |
US8048409B2 (en) * | 2004-05-27 | 2011-11-01 | Medtronic Vascular, Inc. | Cellular therapy to heal vascular tissue |
US20050266042A1 (en) * | 2004-05-27 | 2005-12-01 | Medtronic Vascular, Inc. | Methods and apparatus for treatment of aneurysmal tissue |
US20050266043A1 (en) * | 2004-05-27 | 2005-12-01 | Medtronic Vascular, Inc. | Methods and compounds for treatment of aneurysmal tissue |
US20060064155A1 (en) * | 2004-09-01 | 2006-03-23 | Pst, Llc | Stent and method for manufacturing the stent |
US20060074480A1 (en) | 2004-09-01 | 2006-04-06 | Pst, Llc | Stent and method for manufacturing the stent |
WO2006034050A2 (en) * | 2004-09-17 | 2006-03-30 | Cordis Neurovascular, Inc. | Thin film medical devices manufactured on application specific core shapes |
US9012506B2 (en) | 2004-09-28 | 2015-04-21 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US8962023B2 (en) | 2004-09-28 | 2015-02-24 | Atrium Medical Corporation | UV cured gel and method of making |
US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
US7887579B2 (en) * | 2004-09-29 | 2011-02-15 | Merit Medical Systems, Inc. | Active stent |
US7892592B1 (en) | 2004-11-30 | 2011-02-22 | Advanced Cardiovascular Systems, Inc. | Coating abluminal surfaces of stents and other implantable medical devices |
US7632307B2 (en) * | 2004-12-16 | 2009-12-15 | Advanced Cardiovascular Systems, Inc. | Abluminal, multilayer coating constructs for drug-delivery stents |
US20060140867A1 (en) * | 2004-12-28 | 2006-06-29 | Helfer Jeffrey L | Coated stent assembly and coating materials |
US8628565B2 (en) * | 2005-04-13 | 2014-01-14 | Abbott Cardiovascular Systems Inc. | Intravascular stent |
US7731654B2 (en) | 2005-05-13 | 2010-06-08 | Merit Medical Systems, Inc. | Delivery device with viewing window and associated method |
US7823533B2 (en) | 2005-06-30 | 2010-11-02 | Advanced Cardiovascular Systems, Inc. | Stent fixture and method for reducing coating defects |
AU2006270221B2 (en) | 2005-07-15 | 2012-01-19 | Micell Technologies, Inc. | Polymer coatings containing drug powder of controlled morphology |
WO2007011708A2 (en) | 2005-07-15 | 2007-01-25 | Micell Technologies, Inc. | Stent with polymer coating containing amorphous rapamycin |
US7735449B1 (en) | 2005-07-28 | 2010-06-15 | Advanced Cardiovascular Systems, Inc. | Stent fixture having rounded support structures and method for use thereof |
US9278161B2 (en) | 2005-09-28 | 2016-03-08 | Atrium Medical Corporation | Tissue-separating fatty acid adhesion barrier |
US9427423B2 (en) | 2009-03-10 | 2016-08-30 | Atrium Medical Corporation | Fatty-acid based particles |
US20070077435A1 (en) * | 2005-10-05 | 2007-04-05 | Schachter Deborah M | Process for coating a medical device |
US7867547B2 (en) | 2005-12-19 | 2011-01-11 | Advanced Cardiovascular Systems, Inc. | Selectively coating luminal surfaces of stents |
US8840660B2 (en) | 2006-01-05 | 2014-09-23 | Boston Scientific Scimed, Inc. | Bioerodible endoprostheses and methods of making the same |
US9108217B2 (en) | 2006-01-31 | 2015-08-18 | Nanocopoeia, Inc. | Nanoparticle coating of surfaces |
EP2529761B1 (en) * | 2006-01-31 | 2017-06-14 | Nanocopoeia, Inc. | Nanoparticle coating of surfaces |
CA2637883C (en) * | 2006-01-31 | 2015-07-07 | Regents Of The University Of Minnesota | Electrospray coating of objects |
US20070178137A1 (en) * | 2006-02-01 | 2007-08-02 | Toby Freyman | Local control of inflammation |
US8089029B2 (en) | 2006-02-01 | 2012-01-03 | Boston Scientific Scimed, Inc. | Bioabsorbable metal medical device and method of manufacture |
US9456911B2 (en) | 2006-02-14 | 2016-10-04 | Angiomed Gmbh & Co. Medizintechnik | Highly flexible stent and method of manufacture |
US20070203564A1 (en) * | 2006-02-28 | 2007-08-30 | Boston Scientific Scimed, Inc. | Biodegradable implants having accelerated biodegradation properties in vivo |
CA2643720A1 (en) | 2006-02-28 | 2007-09-07 | Debra A. Bebb | Flexible stretch stent-graft |
JP2007229271A (en) * | 2006-03-01 | 2007-09-13 | Tokyo Medical & Dental Univ | Bioadhesive medical device |
US20090014119A1 (en) * | 2006-03-03 | 2009-01-15 | Toho Tenax Europe Gmbh | Process for the Manufacture of Bonded Laid Structures |
US8048150B2 (en) | 2006-04-12 | 2011-11-01 | Boston Scientific Scimed, Inc. | Endoprosthesis having a fiber meshwork disposed thereon |
EP2019657B1 (en) | 2006-04-26 | 2015-05-27 | Micell Technologies, Inc. | Coatings containing multiple drugs |
US7985441B1 (en) | 2006-05-04 | 2011-07-26 | Yiwen Tang | Purification of polymers for coating applications |
US8069814B2 (en) | 2006-05-04 | 2011-12-06 | Advanced Cardiovascular Systems, Inc. | Stent support devices |
US8568764B2 (en) | 2006-05-31 | 2013-10-29 | Advanced Cardiovascular Systems, Inc. | Methods of forming coating layers for medical devices utilizing flash vaporization |
US8603530B2 (en) | 2006-06-14 | 2013-12-10 | Abbott Cardiovascular Systems Inc. | Nanoshell therapy |
US8048448B2 (en) | 2006-06-15 | 2011-11-01 | Abbott Cardiovascular Systems Inc. | Nanoshells for drug delivery |
US8246973B2 (en) | 2006-06-21 | 2012-08-21 | Advanced Cardiovascular Systems, Inc. | Freeze-thaw method for modifying stent coating |
US8017237B2 (en) | 2006-06-23 | 2011-09-13 | Abbott Cardiovascular Systems, Inc. | Nanoshells on polymers |
JP2009545407A (en) | 2006-08-02 | 2009-12-24 | ボストン サイエンティフィック サイムド,インコーポレイテッド | End prosthesis with 3D decomposition control |
US7988720B2 (en) | 2006-09-12 | 2011-08-02 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
JP2010503490A (en) | 2006-09-15 | 2010-02-04 | ボストン サイエンティフィック リミテッド | Endoprosthesis with adjustable surface features |
JP2010503485A (en) | 2006-09-15 | 2010-02-04 | ボストン サイエンティフィック リミテッド | Medical device and method for manufacturing the same |
US8808726B2 (en) | 2006-09-15 | 2014-08-19 | Boston Scientific Scimed. Inc. | Bioerodible endoprostheses and methods of making the same |
ES2368125T3 (en) | 2006-09-15 | 2011-11-14 | Boston Scientific Scimed, Inc. | BIOEROSIONABLE ENDOPROOTHESIS WITH BIOESTABLE INORGANIC LAYERS. |
ATE517590T1 (en) | 2006-09-15 | 2011-08-15 | Boston Scient Ltd | BIOLOGICALLY ERODABLE ENDOPROTHESES |
US20100016946A1 (en) * | 2006-09-18 | 2010-01-21 | C.R. Bard, Inc | Single layer eptfe and discrete bioresorbable rings |
US8002821B2 (en) | 2006-09-18 | 2011-08-23 | Boston Scientific Scimed, Inc. | Bioerodible metallic ENDOPROSTHESES |
US7632570B2 (en) * | 2006-09-20 | 2009-12-15 | Ppg Industries Ohio, Inc. | Aqueous resinous binders |
US8636767B2 (en) * | 2006-10-02 | 2014-01-28 | Micell Technologies, Inc. | Surgical sutures having increased strength |
US9539593B2 (en) | 2006-10-23 | 2017-01-10 | Micell Technologies, Inc. | Holder for electrically charging a substrate during coating |
US9622888B2 (en) * | 2006-11-16 | 2017-04-18 | W. L. Gore & Associates, Inc. | Stent having flexibly connected adjacent stent elements |
US20080132991A1 (en) * | 2006-11-30 | 2008-06-05 | Leonard Pinchuk | Method for Ionically Cross-Linking Gellan Gum for Thin Film Applications and Medical Devices Produced Therefrom |
US9040816B2 (en) * | 2006-12-08 | 2015-05-26 | Nanocopoeia, Inc. | Methods and apparatus for forming photovoltaic cells using electrospray |
ATE488259T1 (en) | 2006-12-28 | 2010-12-15 | Boston Scient Ltd | BIOERODIBLE ENDOPROTHES AND PRODUCTION METHODS THEREOF |
EP2111184B1 (en) | 2007-01-08 | 2018-07-25 | Micell Technologies, Inc. | Stents having biodegradable layers |
US11426494B2 (en) | 2007-01-08 | 2022-08-30 | MT Acquisition Holdings LLC | Stents having biodegradable layers |
WO2008097511A2 (en) | 2007-02-07 | 2008-08-14 | Cook Incorporated | Medical device coatings for releasing a therapeutic agent at multiple rates |
US8333799B2 (en) * | 2007-02-12 | 2012-12-18 | C. R. Bard, Inc. | Highly flexible stent and method of manufacture |
EP2120785B1 (en) | 2007-02-12 | 2021-12-01 | C.R. Bard, Inc. | Highly flexible stent and method of manufacture |
US7938286B2 (en) * | 2007-02-13 | 2011-05-10 | Gateway Plastics, Inc. | Container system |
US9005242B2 (en) | 2007-04-05 | 2015-04-14 | W.L. Gore & Associates, Inc. | Septal closure device with centering mechanism |
JP5443336B2 (en) * | 2007-04-17 | 2014-03-19 | ミセル テクノロジーズ、インコーポレイテッド | Stent with biodegradable layer |
CA2688314C (en) | 2007-05-25 | 2013-12-03 | Micell Technologies, Inc. | Polymer films for medical device coating |
US8048441B2 (en) | 2007-06-25 | 2011-11-01 | Abbott Cardiovascular Systems, Inc. | Nanobead releasing medical devices |
EP2162101B1 (en) | 2007-06-25 | 2019-02-20 | MicroVention, Inc. | Self-expanding prosthesis |
US8052745B2 (en) | 2007-09-13 | 2011-11-08 | Boston Scientific Scimed, Inc. | Endoprosthesis |
WO2009051780A1 (en) * | 2007-10-19 | 2009-04-23 | Micell Technologies, Inc. | Drug coated stents |
US8361538B2 (en) | 2007-12-19 | 2013-01-29 | Abbott Laboratories | Methods for applying an application material to an implantable device |
US8211489B2 (en) * | 2007-12-19 | 2012-07-03 | Abbott Cardiovascular Systems, Inc. | Methods for applying an application material to an implantable device |
US8926688B2 (en) | 2008-01-11 | 2015-01-06 | W. L. Gore & Assoc. Inc. | Stent having adjacent elements connected by flexible webs |
KR100988816B1 (en) * | 2008-01-29 | 2010-10-20 | 신경민 | A stent |
US20090192588A1 (en) * | 2008-01-29 | 2009-07-30 | Taeoong Medical Co., Ltd | Biodegradable double stent |
US8196279B2 (en) | 2008-02-27 | 2012-06-12 | C. R. Bard, Inc. | Stent-graft covering process |
US20130165967A1 (en) | 2008-03-07 | 2013-06-27 | W.L. Gore & Associates, Inc. | Heart occlusion devices |
MX350637B (en) | 2008-04-17 | 2017-09-11 | Micell Technologies Inc | Stents having bioabsorbable layers. |
US7998192B2 (en) | 2008-05-09 | 2011-08-16 | Boston Scientific Scimed, Inc. | Endoprostheses |
US8236046B2 (en) | 2008-06-10 | 2012-08-07 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US9510856B2 (en) | 2008-07-17 | 2016-12-06 | Micell Technologies, Inc. | Drug delivery medical device |
WO2010009335A1 (en) | 2008-07-17 | 2010-01-21 | Micell Technologies, Inc. | Drug delivery medical device |
US7985252B2 (en) | 2008-07-30 | 2011-07-26 | Boston Scientific Scimed, Inc. | Bioerodible endoprosthesis |
US8382824B2 (en) | 2008-10-03 | 2013-02-26 | Boston Scientific Scimed, Inc. | Medical implant having NANO-crystal grains with barrier layers of metal nitrides or fluorides |
US20100087731A1 (en) * | 2008-10-07 | 2010-04-08 | Medtronic Vascular, Inc. | Method for Tracking Degradation of a Biodegradable Stent Having Superparamagnetic Iron Oxide Particles Embedded Therein |
US20100131001A1 (en) * | 2008-11-24 | 2010-05-27 | Medtronic Vascular, Inc. | Targeted Drug Delivery for Aneurysm Treatment |
US20100131051A1 (en) * | 2008-11-24 | 2010-05-27 | Medtronic Vascular, Inc. | Systems and Methods for Treatment of Aneurysms Using Zinc Chelator(s) |
US20100152832A1 (en) * | 2008-12-12 | 2010-06-17 | Medtronic Vascular, Inc. | Apparatus and Methods for Treatment of Aneurysms With Fibrin Derived Peptide B-Beta |
US8834913B2 (en) | 2008-12-26 | 2014-09-16 | Battelle Memorial Institute | Medical implants and methods of making medical implants |
US8178030B2 (en) | 2009-01-16 | 2012-05-15 | Zeus Industrial Products, Inc. | Electrospinning of PTFE with high viscosity materials |
US20130268062A1 (en) | 2012-04-05 | 2013-10-10 | Zeus Industrial Products, Inc. | Composite prosthetic devices |
EP2403546A2 (en) | 2009-03-02 | 2012-01-11 | Boston Scientific Scimed, Inc. | Self-buffering medical implants |
US8361334B2 (en) * | 2009-03-18 | 2013-01-29 | Medtronic, Inc. | Plasma deposition to increase adhesion |
US8524097B2 (en) * | 2009-03-18 | 2013-09-03 | Medtronic, Inc. | Plasma deposition to increase adhesion |
WO2010111232A2 (en) * | 2009-03-23 | 2010-09-30 | Micell Technologies, Inc. | Drug delivery medical device |
CA2756388C (en) * | 2009-03-23 | 2015-10-27 | Micell Technologies, Inc. | Biodegradable polymers with low acidic impurity |
EP2410954A4 (en) * | 2009-03-23 | 2014-03-05 | Micell Technologies Inc | Peripheral stents having layers |
CN102481195B (en) | 2009-04-01 | 2015-03-25 | 米歇尔技术公司 | Drug delivery medical device |
CA2759015C (en) | 2009-04-17 | 2017-06-20 | James B. Mcclain | Stents having controlled elution |
WO2010143200A2 (en) | 2009-06-11 | 2010-12-16 | Indian Institute Of Technology | A coronary stent with nano coating of drug free polymer and a process for preparation thereof |
US20100318176A1 (en) * | 2009-06-16 | 2010-12-16 | Shannon Donald T | Enhanced systems processes and associated methods for laser trimming of grafts |
US8956389B2 (en) | 2009-06-22 | 2015-02-17 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US20120029556A1 (en) | 2009-06-22 | 2012-02-02 | Masters Steven J | Sealing device and delivery system |
DE102009037134A1 (en) * | 2009-07-31 | 2011-02-03 | Aesculap Ag | Tubular implant for replacement of natural blood vessels |
JP5456892B2 (en) | 2009-08-07 | 2014-04-02 | ゼウス インダストリアル プロダクツ インコーポレイテッド | Multilayer composite |
US20110038910A1 (en) | 2009-08-11 | 2011-02-17 | Atrium Medical Corporation | Anti-infective antimicrobial-containing biomaterials |
WO2011061295A1 (en) | 2009-11-19 | 2011-05-26 | Blue Medical Devices Bv | Narrow profile composition-releasing expandable medical balloon catheter |
EP2338534A2 (en) * | 2009-12-21 | 2011-06-29 | Biotronik VI Patent AG | Medical implant, coating method and implantation method |
US20110319976A1 (en) * | 2010-01-27 | 2011-12-29 | Sriram Iyer | Device and method for preventing stenosis at an anastomosis site |
WO2011097103A1 (en) | 2010-02-02 | 2011-08-11 | Micell Technologies, Inc. | Stent and stent delivery system with improved deliverability |
WO2011109447A1 (en) * | 2010-03-02 | 2011-09-09 | University Of Rochester | Implantable devices that generate low intensity electric fields for the treatment of atherosclerotic disease and prevention of ischemic vascular events and methods of manufacture |
US8668732B2 (en) | 2010-03-23 | 2014-03-11 | Boston Scientific Scimed, Inc. | Surface treated bioerodible metal endoprostheses |
US8795762B2 (en) | 2010-03-26 | 2014-08-05 | Battelle Memorial Institute | System and method for enhanced electrostatic deposition and surface coatings |
US8685433B2 (en) | 2010-03-31 | 2014-04-01 | Abbott Cardiovascular Systems Inc. | Absorbable coating for implantable device |
WO2011133655A1 (en) | 2010-04-22 | 2011-10-27 | Micell Technologies, Inc. | Stents and other devices having extracellular matrix coating |
WO2012009707A2 (en) | 2010-07-16 | 2012-01-19 | Atrium Medical Corporation | Composition and methods for altering the rate of hydrolysis of cured oil-based materials |
US20130172853A1 (en) | 2010-07-16 | 2013-07-04 | Micell Technologies, Inc. | Drug delivery medical device |
US9636309B2 (en) | 2010-09-09 | 2017-05-02 | Micell Technologies, Inc. | Macrolide dosage forms |
CN103561682A (en) | 2011-01-28 | 2014-02-05 | 梅瑞特医药体系股份有限公司 | Electrospun PTFE coated stent and method of use |
JP2014522263A (en) | 2011-05-11 | 2014-09-04 | マイクロベンション インコーポレイテッド | Device for occluding a lumen |
WO2012166819A1 (en) | 2011-05-31 | 2012-12-06 | Micell Technologies, Inc. | System and process for formation of a time-released, drug-eluting transferable coating |
US8632847B2 (en) * | 2011-07-13 | 2014-01-21 | Abbott Cardiovascular Systems Inc. | Methods of manufacture of bioresorbable and durable stents with grooved lumenal surfaces for enhanced re-endothelialization |
CA2841360A1 (en) | 2011-07-15 | 2013-01-24 | Micell Technologies, Inc. | Drug delivery medical device |
US9770232B2 (en) | 2011-08-12 | 2017-09-26 | W. L. Gore & Associates, Inc. | Heart occlusion devices |
US10188772B2 (en) | 2011-10-18 | 2019-01-29 | Micell Technologies, Inc. | Drug delivery medical device |
WO2013109528A1 (en) | 2012-01-16 | 2013-07-25 | Merit Medical Systems, Inc. | Rotational spun material covered medical appliances and methods of manufacture |
ES2943709T3 (en) | 2012-04-06 | 2023-06-15 | Merlin Md Pte Ltd | Devices to treat an aneurysm |
US9867880B2 (en) | 2012-06-13 | 2018-01-16 | Atrium Medical Corporation | Cured oil-hydrogel biomaterial compositions for controlled drug delivery |
US10507268B2 (en) * | 2012-09-19 | 2019-12-17 | Merit Medical Systems, Inc. | Electrospun material covered medical appliances and methods of manufacture |
US10828019B2 (en) | 2013-01-18 | 2020-11-10 | W.L. Gore & Associates, Inc. | Sealing device and delivery system |
CN110269959A (en) | 2013-03-12 | 2019-09-24 | 脉胜医疗技术公司 | Bioabsorbable biomedical implants |
WO2014159399A1 (en) | 2013-03-13 | 2014-10-02 | Merit Medical Systems, Inc. | Methods, systems, and apparatuses for manufacturing rotational spun appliances |
US10799617B2 (en) | 2013-03-13 | 2020-10-13 | Merit Medical Systems, Inc. | Serially deposited fiber materials and associated devices and methods |
US20140277381A1 (en) * | 2013-03-14 | 2014-09-18 | W. L. Gore & Associates, Inc. | Methods and apparatus for assembling stent-grafts |
US10272606B2 (en) | 2013-05-15 | 2019-04-30 | Micell Technologies, Inc. | Bioabsorbable biomedical implants |
US9808230B2 (en) | 2014-06-06 | 2017-11-07 | W. L. Gore & Associates, Inc. | Sealing device and delivery system |
US9895243B2 (en) | 2014-07-17 | 2018-02-20 | W. L. Gore & Associates, Inc. | Stent having adjacent elements connected by narrow flexible webs |
US10111741B2 (en) * | 2014-10-29 | 2018-10-30 | W. L. Gore & Associates, Inc. | Intralumenal stent graft fixation |
US10299948B2 (en) | 2014-11-26 | 2019-05-28 | W. L. Gore & Associates, Inc. | Balloon expandable endoprosthesis |
DK3261589T3 (en) | 2015-02-26 | 2020-12-14 | Merit Medical Systems Inc | LAYERED MEDICAL FACILITIES |
JP2018529394A (en) * | 2015-07-19 | 2018-10-11 | サンフォード ヘルス | Bridge stent graft having combined balloon expandable stent and self-expandable stent and method of use thereof |
US10568752B2 (en) | 2016-05-25 | 2020-02-25 | W. L. Gore & Associates, Inc. | Controlled endoprosthesis balloon expansion |
US10335264B2 (en) * | 2017-03-10 | 2019-07-02 | Byung Choo Moon | Vascular graft |
EP3398620B1 (en) * | 2017-05-05 | 2022-02-23 | Dentsply IH AB | Antibacterial coating or surface comprising vertical, standing angstrom scale flakes |
US11583313B1 (en) | 2018-12-06 | 2023-02-21 | Spiway Llc | Surgical access sheath and methods of use |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5669936A (en) | 1983-12-09 | 1997-09-23 | Endovascular Technologies, Inc. | Endovascular grafting system and method for use therewith |
US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4925710A (en) | 1988-03-31 | 1990-05-15 | Buck Thomas F | Ultrathin-wall fluoropolymer tube with removable fluoropolymer core |
US5123917A (en) | 1990-04-27 | 1992-06-23 | Lee Peter Y | Expandable intraluminal vascular graft |
WO1992002345A1 (en) | 1990-08-02 | 1992-02-20 | Ronald Kempin | Chisel for dust-free chasing of brick structures |
DE9117152U1 (en) | 1990-10-09 | 1996-07-11 | Cook Inc | Stent |
US5151105A (en) | 1991-10-07 | 1992-09-29 | Kwan Gett Clifford | Collapsible vessel sleeve implant |
US5395349A (en) | 1991-12-13 | 1995-03-07 | Endovascular Technologies, Inc. | Dual valve reinforced sheath and method |
US5507771A (en) | 1992-06-15 | 1996-04-16 | Cook Incorporated | Stent assembly |
US5466509A (en) | 1993-01-15 | 1995-11-14 | Impra, Inc. | Textured, porous, expanded PTFE |
CA2169549C (en) | 1993-08-18 | 2000-07-11 | James D. Lewis | A tubular intraluminal graft |
US5735892A (en) | 1993-08-18 | 1998-04-07 | W. L. Gore & Associates, Inc. | Intraluminal stent graft |
US6027779A (en) | 1993-08-18 | 2000-02-22 | W. L. Gore & Associates, Inc. | Thin-wall polytetrafluoroethylene tube |
AU6943794A (en) | 1993-08-18 | 1995-03-14 | W.L. Gore & Associates, Inc. | A thin-wall, seamless, porous polytetrafluoroethylene tube |
US5389106A (en) | 1993-10-29 | 1995-02-14 | Numed, Inc. | Impermeable expandable intravascular stent |
US5463010A (en) * | 1993-11-12 | 1995-10-31 | Surface Engineering Technologies, Division Of Innerdyne, Inc. | Hydrocyclosiloxane membrane prepared by plasma polymerization process |
US5443497A (en) * | 1993-11-22 | 1995-08-22 | The Johns Hopkins University | Percutaneous prosthetic by-pass graft and method of use |
US5554181A (en) * | 1994-05-04 | 1996-09-10 | Regents Of The University Of Minnesota | Stent |
US5575816A (en) * | 1994-08-12 | 1996-11-19 | Meadox Medicals, Inc. | High strength and high density intraluminal wire stent |
US5575818A (en) | 1995-02-14 | 1996-11-19 | Corvita Corporation | Endovascular stent with locking ring |
WO1996025897A2 (en) | 1995-02-22 | 1996-08-29 | Menlo Care, Inc. | Covered expanding mesh stent |
DE69518337T2 (en) | 1995-03-10 | 2001-02-01 | Impra Inc | ENDOLUMINAL ENCLOSED STENT AND MANUFACTURING METHOD |
US6124523A (en) | 1995-03-10 | 2000-09-26 | Impra, Inc. | Encapsulated stent |
US6053943A (en) * | 1995-12-08 | 2000-04-25 | Impra, Inc. | Endoluminal graft with integral structural support and method for making same |
US6264684B1 (en) * | 1995-03-10 | 2001-07-24 | Impra, Inc., A Subsidiary Of C.R. Bard, Inc. | Helically supported graft |
US5562697A (en) | 1995-09-18 | 1996-10-08 | William Cook, Europe A/S | Self-expanding stent assembly and methods for the manufacture thereof |
US5824037A (en) | 1995-10-03 | 1998-10-20 | Medtronic, Inc. | Modular intraluminal prostheses construction and methods |
US5591195A (en) | 1995-10-30 | 1997-01-07 | Taheri; Syde | Apparatus and method for engrafting a blood vessel |
US5628788A (en) | 1995-11-07 | 1997-05-13 | Corvita Corporation | Self-expanding endoluminal stent-graft |
US5788626A (en) | 1995-11-21 | 1998-08-04 | Schneider (Usa) Inc | Method of making a stent-graft covered with expanded polytetrafluoroethylene |
US5800512A (en) | 1996-01-22 | 1998-09-01 | Meadox Medicals, Inc. | PTFE vascular graft |
US5713949A (en) | 1996-08-06 | 1998-02-03 | Jayaraman; Swaminathan | Microporous covered stents and method of coating |
US5888591A (en) | 1996-05-06 | 1999-03-30 | Massachusetts Institute Of Technology | Chemical vapor deposition of fluorocarbon polymer thin films |
US5928279A (en) * | 1996-07-03 | 1999-07-27 | Baxter International Inc. | Stented, radially expandable, tubular PTFE grafts |
WO1998012990A1 (en) * | 1996-09-26 | 1998-04-02 | Scimed Life Systems, Inc. | Support structure/membrane composite medical device |
US5858556A (en) | 1997-01-21 | 1999-01-12 | Uti Corporation | Multilayer composite tubular structure and method of making |
US5957974A (en) * | 1997-01-23 | 1999-09-28 | Schneider (Usa) Inc | Stent graft with braided polymeric sleeve |
US6139573A (en) * | 1997-03-05 | 2000-10-31 | Scimed Life Systems, Inc. | Conformal laminate stent device |
US5851232A (en) | 1997-03-15 | 1998-12-22 | Lois; William A. | Venous stent |
US5843172A (en) * | 1997-04-15 | 1998-12-01 | Advanced Cardiovascular Systems, Inc. | Porous medicated stent |
US5891507A (en) | 1997-07-28 | 1999-04-06 | Iowa-India Investments Company Limited | Process for coating a surface of a metallic stent |
US6488701B1 (en) * | 1998-03-31 | 2002-12-03 | Medtronic Ave, Inc. | Stent-graft assembly with thin-walled graft component and method of manufacture |
US6129757A (en) * | 1998-05-18 | 2000-10-10 | Scimed Life Systems | Implantable members for receiving therapeutically useful compositions |
EP1726271B1 (en) * | 1998-09-30 | 2012-07-25 | Bard Peripheral Vascular, Inc. | Selective adherence of stentgraft coverings, mandrel and method of making stent-graft device |
US6364903B2 (en) * | 1999-03-19 | 2002-04-02 | Meadox Medicals, Inc. | Polymer coated stent |
-
1999
- 1999-03-19 US US09/272,538 patent/US6364903B2/en not_active Expired - Lifetime
-
2000
- 2000-03-06 DE DE60019911T patent/DE60019911T2/en not_active Expired - Lifetime
- 2000-03-06 JP JP2000606156A patent/JP4672869B2/en not_active Expired - Fee Related
- 2000-03-06 EP EP00917783A patent/EP1164972B1/en not_active Expired - Lifetime
- 2000-03-06 CA CA002366665A patent/CA2366665C/en not_active Expired - Fee Related
- 2000-03-06 WO PCT/US2000/005976 patent/WO2000056247A1/en active IP Right Grant
-
2002
- 2002-02-05 US US10/067,584 patent/US6733524B2/en not_active Expired - Fee Related
-
2004
- 2004-03-24 US US10/807,700 patent/US7285132B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6364903B2 (en) | 2002-04-02 |
US6733524B2 (en) | 2004-05-11 |
JP4672869B2 (en) | 2011-04-20 |
US20040181278A1 (en) | 2004-09-16 |
US7285132B2 (en) | 2007-10-23 |
US20010049551A1 (en) | 2001-12-06 |
DE60019911D1 (en) | 2005-06-09 |
US20020091437A1 (en) | 2002-07-11 |
JP2002540822A (en) | 2002-12-03 |
DE60019911T2 (en) | 2006-01-26 |
WO2000056247A1 (en) | 2000-09-28 |
EP1164972B1 (en) | 2005-05-04 |
EP1164972A1 (en) | 2002-01-02 |
CA2366665A1 (en) | 2000-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2366665C (en) | Polymer coated stent | |
US6143022A (en) | Stent-graft assembly with dual configuration graft component and method of manufacture | |
US6488701B1 (en) | Stent-graft assembly with thin-walled graft component and method of manufacture | |
EP1093772B1 (en) | Expandable supportive bifurcated endoluminal grafts | |
US6309413B1 (en) | Expandable supportive endoluminal grafts | |
JP3927545B2 (en) | Tubular PTFE graft with radially expandable stent | |
CA2234976C (en) | Expandable supportive branched endoluminal grafts | |
CA2566929C (en) | Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery | |
US5749880A (en) | Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery | |
EP0938879A2 (en) | Stent-graft assembly and method of manufacture | |
US20080221668A1 (en) | Expandable supportive branched endoluminal grafts | |
WO1997017913A9 (en) | Expandable supportive branched endoluminal grafts | |
AU736081B2 (en) | Expandable supportive bifurcated endoluminal grafts | |
AU6540199A (en) | Endoluminal component with indent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20150306 |